SUPRIYABSESUPRIYA LIFESCIENCE LTDMediumNeutral
Announced Tue, 18 Aug · 16:37 IST

Q1 FY27: Revenue up 31% YoY at Rs 190 cr, EBITDA margin dips to 25% on one-offs

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.1%1-day move
₹803.40
prior close
₹811.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.2-1.4-1.6+1.1+0.3
Up moveDown movePending
AI summary

Revenue rose 31% YoY to Rs 190 cr but EBITDA fell 8% to Rs 47 cr with margins at 25%, hit by Rs 35 cr sales deferment from water shortage and Rs 8 cr solar policy cost impact. Management called these temporary, reiterated Rs 1,000 cr FY27 revenue target and 32-35% EBITDA margin guidance. Patalganga Phase-1 CapEx of Rs 200 cr approved.

Likely market impact

Temporary margin pressure from one-off costs; management confident of recovery to FY27 targets. Patalganga expansion underpins growth.